Is IRhythm Technologies Stock a Good Investment?

IRhythm Technologies Investment Advice

  IRTC
To provide specific investment advice or recommendations on iRhythm Technologies stock, we recommend investors consider the following general factors when evaluating iRhythm Technologies. This will help you to make an informed decision on whether to include IRhythm Technologies in one of your diversified portfolios:
  • Examine IRhythm Technologies' financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
  • Research IRhythm Technologies' leadership team and their track record. Good management can help IRhythm Technologies navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
  • Consider the overall health of the Health Care Equipment & Supplies space and any emerging trends that could impact IRhythm Technologies' business and its evolving consumer preferences.
  • Compare IRhythm Technologies' performance and market position to its competitors. Analyze how IRhythm Technologies is positioned in terms of product offerings, innovation, and market share.
  • Check if IRhythm Technologies pays a dividend and its dividend yield and payout ratio.
  • Review what financial analysts are saying about IRhythm Technologies' stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in iRhythm Technologies stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if iRhythm Technologies is a good investment.
 
Sell
 
Buy
Strong Buy
Macroaxis provides investment recommendation on IRhythm Technologies to complement and cross-verify current analyst consensus on iRhythm Technologies. Our trade recommendations engine determines the entity's potential to grow exclusively from the perspective of an investor's current risk tolerance and investing horizon. To make sure iRhythm Technologies is not overpriced, please check out all IRhythm Technologies fundamentals, including its shares owned by institutions, net income, short ratio, as well as the relationship between the price to sales and debt to equity . Given that iRhythm Technologies has a number of shares shorted of 2.63 M, we strongly advise you to confirm iRhythm Technologies market performance and probability of bankruptcy to ensure the company can sustain itself in the current economic cycle given your regular risk tolerance and investing horizon.

Market Performance

OKDetails

Volatility

Very steadyDetails

Hype Condition

StaleDetails

Current Valuation

UndervaluedDetails

Odds Of Distress

LowDetails

Economic Sensitivity

Follows the market closelyDetails

Investor Sentiment

ImpartialDetails

Analyst Consensus

Strong BuyDetails

Financial Leverage

Not RatedDetails

Reporting Quality (M-Score)

UnavailableDetails

Examine IRhythm Technologies Stock

Researching IRhythm Technologies' stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 99.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 3.64. iRhythm Technologies had not issued any dividends in recent years.
To determine if IRhythm Technologies is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding IRhythm Technologies' research are outlined below:
The company reported the previous year's revenue of 591.84 M. Net Loss for the year was (113.29 M) with profit before overhead, payroll, taxes, and interest of 407.53 M.
Over 99.0% of the company shares are owned by institutional investors
Latest headline from news.google.com: 3 Healthcare Stocks in the Doghouse - Yahoo Finance

IRhythm Technologies Quarterly Good Will

862,000

IRhythm Technologies uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in iRhythm Technologies. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to IRhythm Technologies' previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
22nd of February 2024
Upcoming Quarterly Report
View
2nd of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
22nd of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View
Earnings surprises can significantly impact IRhythm Technologies' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises IRhythm Technologies' investors have experienced.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2017-05-03
2017-03-31-0.34-0.240.129 
2022-08-04
2022-06-30-0.91-0.80.1112 
2018-05-02
2018-03-31-0.36-0.47-0.1130 
2017-02-15
2016-12-31-0.26-0.37-0.1142 
2021-05-06
2021-03-31-0.83-0.95-0.1214 
2020-02-27
2019-12-31-0.53-0.65-0.1222 
2018-08-01
2018-06-30-0.39-0.51-0.1230 
2018-02-14
2017-12-31-0.35-0.48-0.1337 

Know IRhythm Technologies' Top Institutional Investors

Have you ever been surprised when a price of an equity instrument such as IRhythm Technologies is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading iRhythm Technologies backward and forwards among themselves. IRhythm Technologies' institutional investor refers to the entity that pools money to purchase IRhythm Technologies' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Champlain Investment Partners, Llc2024-12-31
726.3 K
Jpmorgan Chase & Co2024-12-31
706.8 K
Braidwell Lp2024-12-31
705.4 K
Blair William & Co2024-12-31
604.7 K
Allspring Global Investments Holdings, Llc2024-12-31
570 K
Bessemer Group Inc2024-12-31
568 K
Slate Path Capital Lp2024-12-31
510.5 K
Stephens Inv Mgmt Group Llc2024-12-31
502.9 K
Bank Of New York Mellon Corp2024-12-31
491.5 K
Sands Capital Management, Llc2024-12-31
3.2 M
Vanguard Group Inc2024-12-31
3.1 M
Note, although IRhythm Technologies' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

IRhythm Technologies' market capitalization trends

The company currently falls under 'Mid-Cap' category with a current market capitalization of 3.35 B.

Market Cap

1.63 Billion

IRhythm Technologies' profitablity analysis

Last ReportedProjected for Next Year
Return On Tangible Assets(0.12)(0.13)
Return On Capital Employed(0.14)(0.15)
Return On Assets(0.12)(0.13)
Return On Equity(1.25)(1.18)
The company has Profit Margin (PM) of (0.19) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.01) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.01.
Determining IRhythm Technologies' profitability involves analyzing its financial statements and using various financial metrics to determine if IRhythm Technologies is a good buy. For example, gross profit margin measures IRhythm Technologies' profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of IRhythm Technologies' profitability and make more informed investment decisions.
Please note, the presentation of IRhythm Technologies' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, IRhythm Technologies' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of IRhythm Technologies' management manipulating its earnings.

Evaluate IRhythm Technologies' management efficiency

iRhythm Technologies has return on total asset (ROA) of (0.0654) % which means that it has lost $0.0654 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.7527) %, meaning that it created substantial loss on money invested by shareholders. IRhythm Technologies' management efficiency ratios could be used to measure how well IRhythm Technologies manages its routine affairs as well as how well it operates its assets and liabilities. As of March 26, 2025, Return On Tangible Assets is expected to decline to -0.13. In addition to that, Return On Capital Employed is expected to decline to -0.15. At present, IRhythm Technologies' Net Tangible Assets are projected to increase significantly based on the last few years of reporting. The current year's Non Current Assets Total is expected to grow to about 299.9 M, whereas Other Assets are forecasted to decline to about 19.3 M.
Last ReportedProjected for Next Year
Book Value Per Share 2.91  3.98 
Tangible Book Value Per Share 2.89  3.90 
Enterprise Value Over EBITDA(42.23)(44.34)
Price Book Value Ratio 30.94  32.49 
Enterprise Value Multiple(42.23)(44.34)
Price Fair Value 30.94  32.49 
Enterprise Value2.6 B1.6 B
Understanding the operational decisions made by IRhythm Technologies management offers insights into its financial robustness. This evaluation is crucial for assessing the stock's investment potential.
Beta
1.362

Basic technical analysis of IRhythm Stock

As of the 26th of March, IRhythm Technologies retains the Risk Adjusted Performance of 0.0925, market risk adjusted performance of 0.4269, and Downside Deviation of 2.79. IRhythm Technologies technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.

IRhythm Technologies' insider trading activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific IRhythm Technologies insiders, such as employees or executives, is commonly permitted as long as it does not rely on IRhythm Technologies' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases IRhythm Technologies insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Chad Patterson over two weeks ago
Acquisition by Chad Patterson of 10742 shares of IRhythm Technologies subject to Rule 16b-3
 
Chad Patterson over two months ago
Acquisition by Chad Patterson of 10674 shares of IRhythm Technologies subject to Rule 16b-3
 
Murphy Patrick Michael over three months ago
Disposition of 2492 shares by Murphy Patrick Michael of IRhythm Technologies at 85.89 subject to Rule 16b-3
 
Daniel Wilson over three months ago
Disposition of 2452 shares by Daniel Wilson of IRhythm Technologies at 111.14 subject to Rule 16b-3
 
Mark Day over six months ago
Disposition of 1475 shares by Mark Day of IRhythm Technologies at 121.96 subject to Rule 16b-3
 
Bobzien Brice over six months ago
Disposition of 1372 shares by Bobzien Brice of IRhythm Technologies at 70.34 subject to Rule 16b-3
 
Bodaken Bruce G. over six months ago
Acquisition by Bodaken Bruce G. of 1396 shares of IRhythm Technologies subject to Rule 16b-3
 
Turakhia Minang over six months ago
Disposition of 1404 shares by Turakhia Minang of IRhythm Technologies at 105.65 subject to Rule 16b-3
 
Sumi Shrishrimal over six months ago
Disposition of 1131 shares by Sumi Shrishrimal of IRhythm Technologies at 88.91 subject to Rule 16b-3
 
Daniel Wilson over six months ago
Acquisition by Daniel Wilson of 2228 shares of IRhythm Technologies subject to Rule 16b-3
 
Sumi Shrishrimal over six months ago
Disposition of 1109 shares by Sumi Shrishrimal of IRhythm Technologies at 111.45 subject to Rule 16b-3
 
Murphy Patrick Michael over six months ago
Disposition of 1704 shares by Murphy Patrick Michael of IRhythm Technologies at 106.78 subject to Rule 16b-3

IRhythm Technologies' Outstanding Corporate Bonds

IRhythm Technologies issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. iRhythm Technologies uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most IRhythm bonds can be classified according to their maturity, which is the date when iRhythm Technologies has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Understand IRhythm Technologies' technical and predictive indicators

Using predictive indicators to make investment decisions involves analyzing IRhythm Technologies' various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.

Consider IRhythm Technologies' intraday indicators

IRhythm Technologies intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of IRhythm Technologies stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

IRhythm Technologies Corporate Filings

F4
4th of March 2025
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
8K
20th of February 2025
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
14th of February 2025
Other Reports
ViewVerify
13th of February 2025
Other Reports
ViewVerify
IRhythm Technologies time-series forecasting models is one of many IRhythm Technologies' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary IRhythm Technologies' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

IRhythm Stock media impact

Far too much social signal, news, headlines, and media speculation about IRhythm Technologies that are available to investors today. That information is available publicly through IRhythm media outlets and privately through word of mouth or via IRhythm internal channels. However, regardless of the origin, that massive amount of IRhythm data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of IRhythm Technologies news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of IRhythm Technologies relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to IRhythm Technologies' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive IRhythm Technologies alpha.

IRhythm Technologies Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards IRhythm Technologies can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

iRhythm Technologies Historical Investor Sentiment

Investor biases related to IRhythm Technologies' public news can be used to forecast risks associated with an investment in IRhythm. The trend in average sentiment can be used to explain how an investor holding IRhythm can time the market purely based on public headlines and social activities around iRhythm Technologies. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
IRhythm Technologies' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for IRhythm Technologies and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average IRhythm Technologies news discussions. The higher the estimate score, the more favorable the investor's outlook on IRhythm Technologies.

IRhythm Technologies Maximum Pain Price Across May 16th 2025 Option Contracts

IRhythm Technologies' options can also be used to analyze investors' bias and current market sentiment in the context of behavioral finance. For example, Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of IRhythm Technologies close to the expiration of its current option contract to expire worthlessly. According to most research, about 35% of options are not executed, with roughly 50% traded out before expiration. So, Max pain occurs when market makers reach a net favorable position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthlessly. Please continue to view the detailed analysis of IRhythm Technologies' options.

IRhythm Technologies Corporate Management

Chad PattersonChief OfficerProfile
Brice CPAChief OfficerProfile
Mazi KianiVP RegulatoryProfile
Daniel WilsonExecutive RelationsProfile
Mintu MDChief OfficerProfile
MS MDChief InnovationProfile
Mervin SmithExecutive OperationsProfile
When determining whether iRhythm Technologies offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of IRhythm Technologies' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Irhythm Technologies Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Irhythm Technologies Stock:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in iRhythm Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
For information on how to trade IRhythm Stock refer to our How to Trade IRhythm Stock guide.
You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of IRhythm Technologies. If investors know IRhythm will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about IRhythm Technologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(3.64)
Revenue Per Share
18.972
Quarterly Revenue Growth
0.24
Return On Assets
(0.07)
Return On Equity
(0.75)
The market value of iRhythm Technologies is measured differently than its book value, which is the value of IRhythm that is recorded on the company's balance sheet. Investors also form their own opinion of IRhythm Technologies' value that differs from its market value or its book value, called intrinsic value, which is IRhythm Technologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because IRhythm Technologies' market value can be influenced by many factors that don't directly affect IRhythm Technologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between IRhythm Technologies' value and its price, as these two are different measures arrived at by various means. Investors typically determine if IRhythm Technologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, IRhythm Technologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.